Clinical Trials List
2020-04-01 - 2032-06-30
Others
Recruiting5
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳文賢 Division of Hematology & Oncology
- 鄧齡喬 Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
- PO-HSIEN LI Division of Hematology & Oncology
- YU-HSUAN SHIH Division of Hematology & Oncology
- PO-WEI LIAO Division of Hematology & Oncology
- ZHENG-WEI ZHOU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsai-Yun Chen Division of General Internal Medicine
- Sin-Syue Li Division of General Internal Medicine
- Ya-Ping Chen Division of General Internal Medicine
- Chun-Hui Lee Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chien Chou Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- 劉高郎 Division of Hematology & Oncology
- 柯紀綸 Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Tai-Chung Huang Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李建霖 Division of Hematology & Oncology
- 許獻文 Division of Hematology & Oncology
- 劉鴻霖 Division of Hematology & Oncology
- 馬銘君 Division of Hematology & Oncology
- 廖碧涵 Division of Hematology & Oncology
- 林偉哲 Division of Hematology & Oncology
- Hong jie Chen Division of Hematology & Oncology
- 邱玲榕 Division of Hematology & Oncology
- 陳韋廷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
612 participants